Goldman Sachs expects Nvidia ’beat and raise,’ lifts price target to $240
Alignment Healthcare Inc. (NASDAQ:ALHC), a healthcare company with a market capitalization of $3.48 billion and impressive year-to-date returns of 56%, saw its Chief Medical Officer, Hyong Kim, sell a total of 85,034 shares of common stock in two separate transactions on October 8 and October 9, 2025, for approximately $1.48 million.
On October 8, Kim sold 33,655 shares at a price of $17.29, totaling $581,894. The following day, October 9, Kim sold 51,379 shares at $17.5713, amounting to $902,795.
Following these transactions, Kim directly owns 362,333 shares of Alignment Healthcare.
In other recent news, Alignment Healthcare reported its second-quarter 2025 earnings, revealing an impressive earnings per share (EPS) of $0.07, which significantly exceeded the forecast of -$0.07. The company’s revenue reached $1 billion, surpassing the expected $960.51 million, indicating strong business growth. Following this solid performance, Barclays upgraded Alignment Healthcare’s stock rating from Underweight to Equalweight, raising the price target to $13.00 from $9.00. KeyBanc also upgraded the stock from Sector Weight to Overweight, citing Alignment Healthcare’s improved hospital utilization and reinvestment in member benefits as key factors.
Additionally, Piper Sandler’s analysis suggests potential Medicare Advantage margin growth in 2026 for Alignment Healthcare based on recent government data. In leadership news, Alignment Healthcare announced the appointment of Matt Eyles as executive vice president of government and business strategy, effective September 29. Eyles will focus on enhancing the company’s healthcare policy engagement and business planning. These developments reflect Alignment Healthcare’s ongoing efforts to adapt and grow within the healthcare industry.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.